Article Impact Level: HIGH Data Quality: STRONG Summary of Diabetes Technology & Therapeutics, https://doi.org/10.1177/15209156251379506 Dr. Jorge A. Rodriguez et al.
Points
- Continuous glucose monitors may not accurately reflect blood sugar control in individuals without diabetes.
- The devices are primarily validated for diabetic populations, where glucose fluctuations are typically larger.
- For healthy individuals, CGM readings often fall within a narrow physiological range, making interpretation challenging.
- Seemingly “abnormal” readings in non-diabetics might represent normal physiological responses, not dysregulation.
- Specific validation protocols and interpretive guidelines are needed for CGM use in non-diabetic populations.
Summary
This research highlights that continuous glucose monitors (CGMs) may not accurately reflect blood sugar control in individuals without diabetes. The study investigated the reliability and interpretability of CGM data for non-diabetic populations, a demographic increasingly utilizing these devices for health monitoring and lifestyle management. Traditional measures of glycemic control, such as HbA1c, are well-established for diabetic patients, but their correlation with CGM readings in healthy individuals and the clinical implications of discrepancies remain less understood.
The findings indicate that while CGMs provide real-time glucose readings, their utility for precisely assessing blood sugar control in non-diabetic individuals might be limited. The devices are primarily calibrated and validated for populations with impaired glucose metabolism, where fluctuations are typically larger and more indicative of clinical pathology. For individuals with robust homeostatic mechanisms, glucose variations captured by CGMs may fall within a narrow physiological range, making it challenging to differentiate normal fluctuations from clinically significant patterns.
This implies that interpretations of CGM data in healthy individuals should be approached with caution, as seemingly “abnormal” readings might simply reflect normal physiological responses rather than actual dysregulation. The study underscores the need for specific validation protocols and interpretive guidelines for CGM use in non-diabetic populations to avoid misinterpretation, unnecessary anxiety, or inappropriate interventions. Further research is warranted to establish precise thresholds and patterns that truly signify compromised blood sugar control in healthy individuals using CGMs.
Link to the article: https://www.liebertpub.com/doi/10.1177/15209156251379506
References
Rodriguez, J. A., Palermo, N. E., Song, W., Lipsitz, S., Caballero, A. E., Samal, L., & Spartano, N. L. (2025). Lack of association between hemoglobin a1c and continuous glucose monitor metrics among individuals with prediabetes and normoglycemia. Diabetes Technology & Therapeutics, 15209156251379506. https://doi.org/10.1177/15209156251379506
